Efficacy Study of PAD and TAD in Newly Diagnosed Multiple Myeloma
Status:
Unknown status
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the efficacy of PAD-regimen and TAD-regimen
in newly diagnosed multiple myeloma(MM).
Phase:
Phase 4
Details
Lead Sponsor:
Second Military Medical University
Collaborators:
Air Force Military Medical University, China Beijing Jishuitan Hospital First Affiliated Hospital, Sun Yat-Sen University Fourth Military Medical University Harbin Hematology and Oncology Institute Harbin Institute of Hematology and Oncology Institute of Hematology & Blood Diseases Hospital Peking University People's Hospital Union hospital of Fujian Medical University Xiangya Hospital of Central South University Zhejiang University